AEs (safety population [N = 100])
AE . | Any grade . | Grade ≥3 . |
---|---|---|
All AEs | 100 (100) | 74 (74) |
Asthenia | 51 (51) | 2 (2) |
Neutropenia* | 48 (48) | 47 (47) |
Constipation | 42 (42) | 0 (0) |
Cough | 36 (36) | 2 (2) |
Diarrhea | 35 (35) | 2 (2) |
Infusion-related reaction | 28 (28) | 3 (3) |
Bronchitis | 27 (27) | 0 (0) |
Decreased weight | 26 (26) | 1 (1) |
Arthralgia | 25 (25) | 0 (0) |
Rash | 25 (25) | 2 (2) |
Rhinitis | 21 (21) | 0 (0) |
Nausea | 18 (18) | 1 (1) |
Nasopharyngitis | 17 (17) | 0 (0) |
Back pain | 15 (15) | 0 (0) |
Pruritus | 15 (15) | 1 (1) |
Urinary tract infection | 15 (15) | 0 (0) |
Peripheral edema | 13 (13) | 1 (1) |
Muscle spasms | 12 (12) | 1 (1) |
Upper abdominal pain | 11 (11) | 0 (0) |
Erythema | 11 (11) | 0 (0) |
Peripheral neuropathy† | 11 (11) | 1 (1) |
Sinusitis | 11 (11) | 0 (0) |
AE . | Any grade . | Grade ≥3 . |
---|---|---|
All AEs | 100 (100) | 74 (74) |
Asthenia | 51 (51) | 2 (2) |
Neutropenia* | 48 (48) | 47 (47) |
Constipation | 42 (42) | 0 (0) |
Cough | 36 (36) | 2 (2) |
Diarrhea | 35 (35) | 2 (2) |
Infusion-related reaction | 28 (28) | 3 (3) |
Bronchitis | 27 (27) | 0 (0) |
Decreased weight | 26 (26) | 1 (1) |
Arthralgia | 25 (25) | 0 (0) |
Rash | 25 (25) | 2 (2) |
Rhinitis | 21 (21) | 0 (0) |
Nausea | 18 (18) | 1 (1) |
Nasopharyngitis | 17 (17) | 0 (0) |
Back pain | 15 (15) | 0 (0) |
Pruritus | 15 (15) | 1 (1) |
Urinary tract infection | 15 (15) | 0 (0) |
Peripheral edema | 13 (13) | 1 (1) |
Muscle spasms | 12 (12) | 1 (1) |
Upper abdominal pain | 11 (11) | 0 (0) |
Erythema | 11 (11) | 0 (0) |
Peripheral neuropathy† | 11 (11) | 1 (1) |
Sinusitis | 11 (11) | 0 (0) |